This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quinn, J P Articles by Levens, D Search for Related Content PubMed PubMed Citation Articles by Quinn, J P Articles by Levens, D

Binding of a cellular protein to the gibbon ape leukemia virus enhancer.

Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The gibbon ape leukemia virus (GALV) contains enhancer activity within its long terminal repeat. In the GALV Seato strain this activity resides in a 48-base-pair (bp) repeated element. We demonstrate the existence of a cellular protein which binds in this region of the Seato strain. A sensitive method for enriching protein-DNA complexes from crude extracts coupled with exonuclease and DNase footprint analysis revealed the specific binding of this protein to a 21-bp region within each repeated element. A 22-bp oligonucleotide fragment defined solely by the 21-bp footprint binds a protein in vitro and displays enhancer activity in vivo, suggesting that this protein is a major determinant of GALV enhancer activity. The protein is present in three cell lines which are positive for enhancer activity and is not detected in Jurkat cells, which are negative for enhancer activity. Only GALV long-terminal-repeat variants which support high levels of enhancer activity in vivo compete with this protein for specific binding in vitro, suggesting a potential role for the protein in determining enhancer activity. This protein binding is not inhibited by competition with heterologous retroviral enhancers, demonstrating that it is not a ubiquitous retroviral enhancer binding protein.

This article has been cited by other articles:

• Guindalini, C., Howard, M., Haddley, K., Laranjeira, R., Collier, D., Ammar, N., Craig, I., O'Gara, C., Bubb, V. J., Greenwood, T., Kelsoe, J., Asherson, P., Murray, R. M., Castelo, A., Quinn, J. P., Vallada, H., Breen, G. (2006). A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc. Natl. Acad. Sci. USA 103: 4552-4557 [Abstract] [Full Text]  
• Rauscher, F J, Voulalas, P J, Franza, B R, Curran, T (1988). Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro.. Genes Dev. 2: 1687-1699 [Abstract]  
• Zajac-Kaye, M, Gelmann, E., Levens, D (1988). A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein. Science 240: 1776-1780 [Abstract]  
• Franza, B. Jr, Rauscher, F. 3rd, Josephs, S., Curran, T (1988). The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 239: 1150-1153 [Abstract]